The Future of Virtual Healthcare
A remote patient bio-marker monitoring and clinical decision support platform.
Medivitals was established in January 2020 with a vision to progress the development of a AI based clinical decision support platform with high sensitivity and specificity for early detection of diseases. Drawing on a strong background in digital health, telemedicine and health informatics, the company has moved into the early stages of development with a focus on using the latest technology to innovate the future of Virtual Healthcare.
The Medivitals solution will focus on significant opportunities in hospitals, emergency clinics, aged care facilities, remote and rural areas, mining sites and quarantine hotels/homes.
Product & Software
The Medivitals Bio-Band measures 5 vital signs
- Body temperature
- Pulse rate
- Respiration rate (rate of breathing)
- Blood pressure
- SpO2 or Oxygen saturation
The proposed bio-band device will have long battery life and use non-allergic material. The bio-band will send all data to a cloud-based data storage using Bluetooth or via an embedded SIM.
Medivitals Data, Monitoring and Analysis Platform
These measures are recorded on the Medivitals Data platform where cloud-based software can manage:
- Disease specific alerts
- Sensor management
- Actuator Control
- Configuration Settings
The Medivitals Data Analytics platform is used to manage sensor data to monitor and define value-based analytics that can drive better health outcomes for patients.
INNOVATING & INVESTING IN THE FUTURE OF VIRTUAL HEALTHCARE
One device for continuous monitoring of multiple vital signs.
Replace bulky devices currently used for manual measurement of vital signs
Aged Care Facilities
Continuous monitoring of vital signs, activity monitoring and falls detection
Remote & Rural Areas
Comprehensive telemedicine consultations with access to biomarkers for evidence based care delivery.
Continuous monitoring of biomarkers from mining staff for flu like symptoms and other diseases.
Home & Hotel Quarantine
INVEST IN THE FUTURE
Get in touch to receive a prospectus for the Medivital’s entry into the AI driven Software Platform.